NNNN Anbio Biotechnology: Earnings growth forecast for next year
Anbio Biotechnology is developing decentralized diagnostics through current POCT solutions. The projected EPS growth rate clearly demonstrates the asset's market position, where 0.00 represents the latest level value. Strategic alliances with clinics are expanding test distribution, although regulatory barriers and the post-pandemic decline in demand create certain risks for the pace of business expansion.
NNNN (Anbio Biotechnology Ltd): analytical breakdowns and indicator data
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization indicators:
- debt and liquidity details:
Total Debt to Capital Anbio Biotechnology|NNNN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity anbio.com|NNNN - Company Cumulative Debt|Debt to Book Value Anbio Tech|NNNN - Company Long-Term Loans and Borrowings|Company Short-Term Debts Anbio Biotechnology|Quick Ratio anbio.com
- net income and valuation ratios data:
NNNN - Net Financial Result|Expected Profit Anbio Biotechnology|NNNN - Market Cap to Earnings|Projected Price to Earnings Anbio Biotechnology|NNNN - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Anbio Biotechnology|NNNN - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Anbio Biotechnology|NNNN - Net earnings per share for the last 12 months|Quarterly EPS earnings growth anbio.com|NNNN - Earnings per share increase in current year|Net earnings per share growth forecast for next year Anbio Biotechnology
- issuer revenue and sales details:
Fundamental company analysis:Anbio Biotechnology
This indicator reflects the analysts' consensus forecast for earnings per share changes, allowing for an assessment of the asset's fundamental value between reporting periods. By analyzing the trend of market expectations for EPS growth, an investor can determine the scaling potential of Anbio Biotechnology through expansion into the home diagnostics segment and the miniaturization of portable analyzers for the global in-vitro market.
Competitor analysis for Anbio Biotechnology
A (agilent.com) - Earnings growth forecast for next year|DGX - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year ILMN|EXAS - Expected net earnings per share growth next year|Earnings growth forecast for next year RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Expected net earnings per share growth next year|Sotera Health Corp - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year QuidelOrtho QDEL|OPK (OPKO Health) - Expected earnings per share growth for next year|Expected net earnings per share growth next year CareDx, Inc. (CDNA)|Expected earnings per share growth for next year MRVI|Expected net earnings per share growth next year Fulgent FLGT|Net earnings per share growth forecast for next year Standard BioTools Inc. (LAB)|CTKB (Cytek Biosciences, Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year OSUR (OraSure Corp)|Consensus forecast of earnings per share growth for next year Exagen Inc. (XGN)|MDXH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Lucid Diagnostics Inc LUCD|PRE (Prenetics Global Ltd) - Expected earnings per share growth for next year|Expected earnings per share growth for next year Insight Molecular|TRIB (Trinity Biotech) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year PRPH|Earnings growth forecast for next year AIMD|Projected earnings per share increase next year CODX|Net earnings per share growth forecast for next year Heart Test Laboratories HSCS|BMRA: Projected earnings per share growth rate for next year|CDIO - Net earnings per share growth forecast for next year|Onconetix Corp (ONCO) - Expected earnings per share growth for next year|VRAX (Virax Biolabs Group Ltd) - Expected earnings per share growth for next year|Expected net earnings per share growth next year Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Earnings growth forecast for next year|AXDX - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year centogene.com (CNTG)|Consensus forecast of earnings per share growth for next year Enzo Biochem|Consensus forecast of earnings per share growth for next year FRES|Net earnings per one share growth forecast for next year GTG Labs|23andMe Holding Co - Earnings growth forecast for next year|PMD - Earnings growth forecast for next year
